http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-05706821-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bf8ddd7435c69cd1b353b1292981d68
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-72
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00
filingDate 2005-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34f02a53adf0d2d5954384ba2f1e9a08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7d2c4279c2ba61aa9fbe0853d58937d
publicationDate 2008-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-05706821-T1
titleOfInvention STEREOSELECTIVE SYNTHESIS OF VITAMIN D ANALOGUE
abstract Process for reducing a compound of general structure III, wherein X is either hydrogen or OR 2 , and wherein R 1 and R 2 may be the same or different and represent hydrogen or a hydroxy protecting group, in an inert solvent with a reducing agent or with a reducing agent in the presence of a chiral auxiliary, to a mixture of compounds of general structure IVa and IVb, which is enriched in IVa, wherein X, R 1 , and R 2 are as defined above.
priorityDate 2004-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6376277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49800068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450257165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426100507
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420332851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453853421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2725045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450796724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420352779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9866743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9833925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455667478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559052

Total number of triples: 45.